Thiogenesis Therapeutics, Corp. (TSXV:TTI)

Canada · Delayed Price · Currency is CAD

0.5500

0.00 (0.00%)

Aug 6, 2026, 2:05 PM EST

Thiogenesis Therapeutics Balance Sheet

Financials in millions CAD. Fiscal year is January - December.

Millions CAD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	7.27	1.62	3.85	7.08	6.2	0.06
Cash & Short-Term Investments	7.27	1.62	3.85	7.08	6.2	0.06
Cash Growth	294.63%	-58.00%	-45.62%	14.21%	9805.77%	225.72%
Accounts Receivable	-	-	-	0.09	-	-
Other Receivables	0.05	0.08	0.09	-	0.06	0.17
Receivables	0.05	0.08	0.09	0.09	0.06	0.17
Prepaid Expenses	0.08	0.12	0.05	0.08	0.04	-
Total Current Assets	7.41	1.81	3.98	7.24	6.29	0.23
Total Assets	7.41	1.81	3.98	7.24	6.29	0.23

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Accounts Payable	0.69	1.24	0.56	1.67	0.31	0.68
Accrued Expenses	-	-	-	0.04	-	0
Short-Term Debt	-	-	-	-	-	0.46
Other Current Liabilities	-	-	-	-	-	0.15
Total Current Liabilities	0.69	1.24	0.56	1.71	0.31	1.29
Total Liabilities	0.69	1.24	0.56	1.71	0.31	1.29

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Common Stock	28.08	19.92	16.14	15.01	11.13	1.05
Additional Paid-In Capital	-	-	-	-	-	0.04
Retained Earnings	-24.11	-21.71	-14.28	-11.14	-6.18	-2.14
Comprehensive Income & Other	2.75	2.36	1.57	1.66	1.03	-0.01
Shareholders' Equity	6.72	0.57	3.43	5.53	5.98	-1.06
Total Liabilities & Equity	7.41	1.81	3.98	7.24	6.29	0.23

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Total Debt	-	-	-	-	-	0.46
Net Cash (Debt)	7.27	1.62	3.85	7.08	6.2	-0.4
Net Cash Growth	294.63%	-58.00%	-45.62%	14.21%	-	-
Net Cash Per Share	0.14	0.03	0.08	0.18	0.24	-0.03
Filing Date Shares Outstanding	57.82	51.84	46.02	44.57	38.86	12
Total Common Shares Outstanding	57.82	51.84	46.02	44.57	38.86	12
Working Capital	6.72	0.57	3.43	5.53	5.98	-1.06
Book Value Per Share	0.12	0.01	0.07	0.12	0.15	-0.09
Tangible Book Value	6.72	0.57	3.43	5.53	5.98	-1.06
Tangible Book Value Per Share	0.12	0.01	0.07	0.12	0.15	-0.09